Results 321 to 330 of about 168,140 (338)
Some of the next articles are maybe not open access.

Related searches:

Durvalumab and tremelimumab with definitive chemoradiotherapy for locally advanced esophageal squamous cell carcinoma

Cancer, 2022
The current standard treatment for patients with inoperable, locally advanced esophageal squamous cell carcinoma (ESCC) is definitive concurrent chemoradiotherapy (CCRT).
Sehhoon Park   +6 more
semanticscholar   +1 more source

Five-year survival outcomes with durvalumab after chemoradiotherapy in unresectable stage III NSCLC: An update from the PACIFIC trial.

, 2021
8511Background: In the placebo-controlled Phase III PACIFIC trial of patients with unresectable Stage III NSCLC whose disease had not progressed after platinum-based concurrent chemoradiotherapy (c...
D. Spigel   +19 more
semanticscholar   +1 more source

Predicting Rectal Cancer Response to Neoadjuvant Chemoradiotherapy Using Deep Learning of Diffusion Kurtosis MRI.

Radiology, 2020
Background Preoperative response evaluation with neoadjuvant chemoradiotherapy remains a challenge in the setting of locally advanced rectal cancer.
Xiaoyan Zhang   +8 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy